糖皮质激素对重症肺炎支原体肺炎的治疗效果分析

Analysis of the effect of glucocorticoid on the treatment of severe Mycoplasma pneumoniae pneumonia

目的：探讨糖皮质激素治疗重症肺炎支原体肺炎的效果。方法：回顾我院2010年1月~2015年12月收治的160例重症肺炎支原体肺炎患者的临床资料,按照随机数字表法分为治疗组（n=80）和对照组（n=80）,对照组予以阿奇霉素进行常规治疗,治疗组在对照组基础上予以糖皮质激素进行治疗,比较两组临床治疗效果。结果：治疗组咳嗽时间、退热时间、住院时间均明显短于对照组（P〈0.05）;两组临床治疗效果比较,治疗组治疗有效率为95.00%（76例）,对照组治疗有效率为70.00%（56例）,治疗组治疗有效率明显高于对照组（P〈0.05）。结论：对重症肺炎支原体肺炎予以糖皮质激素联合阿奇霉素进行治疗,不仅能够缓解临床症状,也能缩短临床治疗时间,有利于提高治疗效果,值得临床推广。

Objective：To investigate the effect of glucocorticoid in the treatment of severe Mycoplasma pneumoniae pneumonia. Methods：Clinical data were reviewed in our hospital in January 2010 ~ 2015 December 160 cases of severe mycoplasma pneumonia pneumonia patients,according to random number table method,divided into the treatment group（n = 80）and control group（n = 80）,patients in control group received azithromycin was given conventional treatment,patients in the treatment group in the control group on the basis of be glucocorticoid treatment,compared two groups of patients with clinical curative effect. Results：Two groups of patients compared patients in the treatment group were cough time,cooling time,length of hospital stay were significantly shorter than that of the control group（P〈0.05）; the clinical therapeutic effect of two groups of patients compared treatment effective rate is 95%（76 cases）and the control of patients in the treatment group the effective rate was 70.00%（56 cases） and treatment effective rate was significantly higher than that of the control group（P〈0.05）. Conclusion：In patients with severe pneumonia mycoplasma pneumonia be glucocorticoid combined with azithromycin treatment,not only can relieve clinical symptoms,but also can shorten the patient＇s clinical treatment time,to improve the treatment effect of patients,it is worth wide clinical application and promotion.